Role of marginal zone B lymphocytes in invariant NKT cell activation

Journal of Immunology

Volumn 182, Issue 10, 2009, Pages 6105-6113

  Bialecki, Emilie ^a,b,c   Paget, Christophe ^a,b,c   Fontaine, Josette ^a,b,c   Capron, Monique ^a,b,c   Trottein, François ^a,b,c   Faveeuw, Christelle ^a,b,c  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 4; OVALBUMIN; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EX VIVO STUDY; HYBRIDOMA; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; MARGINAL ZONE B LYMPHOCYTE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANIMALS; ANTIGENS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; PEPTIDES; SPLEEN; TOLL-LIKE RECEPTORS;

EID: 68049143755     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802273     Document Type: Article

References (60)

1. Martin, F., A. M. Oliver, and J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14: 617-629. (Pubitemid 32520872)
2. Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23: 161-196.
3. Zandvoort, A., and W. Timens. 2002. The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin. Exp. Immunol. 130: 4-11.
4. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162: 7198-7207.
5. Cinamon, G., M. A. Zachariah, O. M. Lam, F. W. Foss, Jr., and J. G. Cyster. 2008. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol. 9: 54-62. (Pubitemid 350286204)
6. Attanavanich, K., and J. F. Kearney. 2004. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J. Immunol. 172: 803-811. (Pubitemid 38113736)
7. Barr, T. A., S. Brown, G. Ryan, J. Zhao, and D. Gray. 2007. TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 37: 3040-3053. (Pubitemid 350131284)
8. Gururajan, M., J. Jacob, and B. Pulendran. 2007. Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets. PLoS ONE. 2:e863. (Pubitemid 351425684)
9. Rubtsov, A. V., C. L. Swanson, S. Troy, P. Strauch, R. Pelanda, and R. M. Torres. 2008. TLR agonists promote marginal zone B cell activation and facilitate T-dependent IgM responses. J. Immunol. 180: 3882-3888.
10. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
11. Godfrey, D. I., and M. Kronenberg. 2004. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114: 1379-1388.
12. Van Kaer, L., and S. Joyce. 2005. Innate immunity: NKT cells in the spotlight. Curr. Biol. 15: R429-R431. (Pubitemid 40772144)
13. Brigl, M., L. Bry, S. C. Kent, J. E. Gumperz, and M. B. Brenner. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4: 1230-1237. (Pubitemid 37540692)
14. Paget, C., T. Mallevaey, A. O. Speak, D. Torres, J. Fontaine, K. C. Sheehan, M. Capron, B. Ryffel, C. Faveeuw, M. Leite de Moraes, F. Platt, and F. Trottein. 2007. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27: 597-609. (Pubitemid 47628833)
15. Salio, M., A. O. Speak, D. Shepherd, P. Polzella, P. A. Illarionov, N. Veerapen, G. S. Besra, F. M. Platt, and V. Cerundolo. 2007. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc. Natl. Acad. Sci. USA 104: 20490-20495.
16. Tupin, E., Y. Kinjo, and M. Kronenberg. 2007. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 5: 405-417. (Pubitemid 46780078)
17. Belperron, A. A., C. M. Dailey, and L. K. Bockenstedt. 2005. Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d. J. Immunol. 174: 5681-5686.
18. Hansen, D. S., M. A. Siomos, T. De Koning-Ward, L. Buckingham, B. S. Crabb, and L. Schofield. 2003. CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses. Eur. J. Immunol. 33: 2588-2598.
19. + T cells. J. Immunol. 174: 1787-1790.
20. Kumar, H., A. Belperron, S. W. Barthold, and L. K. Bockenstedt. 2000. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J. Immunol. 165: 4797-4801.
21. Lang, M. L., and A. Glatman-Freedman. 2006. Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis? Infect. Immun. 74: 803-809.
22. Schofield, L., M. J. McConville, D. Hansen, A. S. Campbell, B. Fraser-Reid, M. J. Grusby, and S. D. Tachado. 1999. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283: 225-229. (Pubitemid 129504603)
23. Takahashi, T., and S. Strober. 2008. Natural killer T cells and innate immune B cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodies. Eur. J. Immunol. 38: 156-165.
24. Galli, G., S. Nuti, S. Tavarini, L. Galli-Stampino, C. De Lalla, G. Casorati, P. Dellabona, and S. Abrignani. 2003. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197: 1051-1057. (Pubitemid 36523203)
25. Lang, G. A., T. S. Devera, and M. L. Lang. 2008. Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production. Blood 111: 2158-2162.
26. Lang, G. A., M. A. Exley, and M. L. Lang. 2006. The CD1d-binding glycolipid α-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner. Immunology 119: 116-125.
27. + invariant natural killer T cells activated by α-galactosylceramide-pulsed B cells promote both IgG and IgE production. Clin. Exp. Immunol. 148: 555-563.
28. Tonti, E., G. Galli, C. Malzone, S. Abrignani, G. Casorati, and P. Dellabona. 2009. NKT-cell help to B lymphocytes can occur independently of cognate interaction. Blood 113: 370-376.
29. Devera, T. S., H. B. Shah, G. A. Lang, and M. L. Lang. 2008. Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers. Eur. J. Immunol. 38: 1001-1011.
30. Galli, G., P. Pittoni, E. Tonti, C. Malzone, Y. Uematsu, M. Tortoli, D. Maione, G. Volpini, O. Finco, S. Nuti, et al. 2007. Invariant NKT cells sustain specific B cell responses and memory. Proc. Natl. Acad. Sci. USA 104: 3984-3989. (Pubitemid 47181565)
31. Ko, S. Y., H. J. Ko, W. S. Chang, S. H. Park, M. N. Kweon, and C. Y. Kang. 2005. α-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J. Immunol. 175: 3309-3317.
32. Barral, P., J. Eckl-Dorna, N. E. Harwood, C. De Santo, M. Salio, P. Illarionov, G. S. Besra, V. Cerundolo, and F. D. Batista. 2008. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo. Proc. Natl. Acad. Sci. USA 105: 8345-8350. (Pubitemid 351904758)
33. Lang, G. A., P. A. Illarionov, A. Glatman-Freedman, G. S. Besra, and M. L. Lang. 2005. BCR targeting of biotin-α-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments. Int. Immunol. 17: 899-908.
34. Leadbetter, E. A., M. Brigl, P. Illarionov, N. Cohen, M. C. Luteran, S. Pillai, G. S. Besra, and M. B. Brenner. 2008. NK T cells provide lipid antigen-specific cognate help for B cells. Proc. Natl. Acad. Sci. USA 105: 8339-8344.
35. Roark, J. H., S. H. Park, J. Jayawardena, U. Kavita, M. Shannon, and A. Bendelac. 1998. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160: 3121-3127.
36. Stetson, D. B., M. Mohrs, R. L. Reinhardt, J. L. Baron, Z. E. Wang, L. Gapin, M. Kronenberg, and R. M. Locksley. 2003. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198: 1069-1076.
37. Mendiratta, S. K., W. D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6: 469-477.
38. Mallevaey, T., J. P. Zanetta, C. Faveeuw, J. Fontaine, E. Maes, F. Platt, M. Capron, M. L. de-Moraes, and F. Trottein. 2006. Activation of invariant NKT cells by the helminth parasite schistosoma mansoni. J. Immunol. 176: 2476-2485.
39. Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17: 1-14.
40. + T cells. J. Exp. Med. 182: 1591-1596.
41. Dougan, S. K., A. Kaser, and R. S. Blumberg. 2007. CD1 expression on antigen-presenting cells. Curr. Top. Microbiol. Immunol. 314: 113-141.
42. Tyznik, A. J., E. Tupin, N. A. Nagarajan, M. J. Her, C. A. Benedict, and M. Kronenberg. 2008. Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J. Immunol. 181: 4452-4456.
43. Mallevaey, T., J. Fontaine, L. Breuilh, C. Paget, A. Castro-Keller, C. Vendeville, M. Capron, M. Leite-de-Moraes, F. Trottein, and C. Faveeuw. 2007. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis. Infect. Immun. 75: 2171-2180.
44. Hammond, K. J., D. G. Pellicci, L. D. Poulton, O. V. Naidenko, A. A. Scalzo, A. G. Baxter, and D. I. Godfrey. 2001. CD1d-restricted NKT cells: an interstrain comparison. J. Immunol. 167: 1164-1173.
45. Hameg, A., I. Apostolou, M. Leite-De-Moraes, J. M. Gombert, C. Garcia, Y. Koezuka, J. F. Bach, and A. Herbelin. 2000. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the α-galactosylceramide antigen. J. Immunol. 165: 4917-4926.
46. Wilson, M. T., C. Johansson, D. Olivares-Villagomez, A. K. Singh, A. K. Stanic, C. R. Wang, S. Joyce, M. J. Wick, and L. Van Kaer. 2003. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. USA 100: 10913-10918.
47. Lopes-Carvalho, T., J. Foote, and J. F. Kearney. 2005. Marginal zone B cells in lymphocyte activation and regulation. Curr. Opin. Immunol. 17: 244-250.
48. Coquet, J. M., K. Kyparissoudis, D. G. Pellicci, G. Besra, S. P. Berzins, M. J. Smyth, and D. I. Godfrey. 2007. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol. 178: 2827-2834. (Pubitemid 46333160)
49. Michel, M. L., A. C. Keller, C. Paget, M. Fujio, F. Trottein, P. B. Savage, C. H. Wong, E. Schneider, M. Dy, and M. C. Leite-de-Moraes. 2007. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204: 995-1001.
50. Sidobre, S., and M. Kronenberg. 2002. CD1 tetramers: a powerful tool for the analysis of glycolipid-reactive T cells. J. Immunol. Methods 268: 107-121. (Pubitemid 35223112)
51. Shimizu, K., Y. Kurosawa, M. Taniguchi, R. M. Steinman, and S. Fujii. 2007. Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J. Exp. Med. 204: 2641-2653.
52. Cheng, L., A. Ueno, S. Cho, J. S. Im, S. Golby, S. Hou, S. A. Porcelli, and Y. Yang. 2007. Efficient activation of Vα14 invariant NKT cells by foreign lipid antigen is associated with concurrent dendritic cell-specific self recognition. J. Immunol. 178: 2755-2762. (Pubitemid 46333152)
53. Kitamura, H., K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, et al. 1999. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189: 1121-1128.
54. Chang, J. H., J. M. Lee, H. J. Youn, K. A. Lee, Y. Chung, A. Y. Lee, M. N. Kweon, H. Y. Kim, M. Taniguchi, and C. Y. Kang. 2008. Functional maturation of lamina propria dendritic cells by activation of NKT cells mediates the abrogation of oral tolerance. Eur. J. Immunol. 38: 2727-2739.
55. Chung, Y., B. S. Kim, Y. J. Kim, H. J. Ko, S. Y. Ko, D. H. Kim, and C. Y. Kang. 2006. CD1d-restricted T cells license B cells to generate long-lasting cytotoxic antitumor immunity in vivo. Cancer Res. 66: 6843-6850. (Pubitemid 44085645)
56. Kim, Y. J., H. J. Ko, Y. S. Kim, D. H. Kim, S. Kang, J. M. Kim, Y. Chung, and C. Y. Kang. 2008. α-Galactosylceramide-loaded, antigen-expressing B cells prime a wide spectrum of antitumor immunity. Int. J. Cancer 122: 2774-2783.
57. Bezbradica, J. S., A. K. Stanic, N. Matsuki, H. Bour-Jordan, J. A. Bluestone, J. W. Thomas, D. Unutmaz, L. Van Kaer, and S. Joyce. 2005. Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo. J. Immunol. 174: 4696-4705. (Pubitemid 40504552)
58. Lu, T. T., and J. G. Cyster. 2002. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297: 409-412. (Pubitemid 34790772)
59. Matsumoto, G., E. Kubota, Y. Omi, U. Lee, and J. M. Penninger. 2004. Essential role of LFA-1 in activating Th2-like responses by α- galactosylceramide-activated NKT cells. J. Immunol. 173: 4976-4984. (Pubitemid 39387780)
60. + cells originate from multiple pathways. J. Immunol. 162: 3753-3756.